Form 4 Tracker
Eric Warren

Chief Commercial Officer · 4 filings · Latest: Sep 21, 2026

Mineralys Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MLYS
Eric WarrenChief Commercial OfficerSep 21, 2026
Sale
$28.127,438$209.1K38,400
MLYS
Eric WarrenChief Commercial OfficerSep 21, 2026
Option Exercise
$13.247,438$98.5K45,838
MLYS
Warren Eric—Sep 21, 2026
Proposed Sale
$28.127,438$209.1K—
MLYS
Eric WarrenChief Commercial OfficerAug 21, 2026
Sale
$25.987,437$193.2K38,400
MLYS
Eric WarrenChief Commercial OfficerAug 21, 2026
Option Exercise
$13.247,437$98.5K45,837
MLYS
Warren Eric—Aug 21, 2026
Proposed Sale
$25.987,437$193.2K—
MLYS
Eric WarrenChief Commercial OfficerJul 21, 2026
Sale
$26.877,438$199.9K38,400
MLYS
Eric WarrenChief Commercial OfficerJul 21, 2026
Option Exercise
$13.247,438$98.5K45,838
MLYS
Warren Eric—Jul 21, 2026
Proposed Sale
$26.877,438$199.9K—
MLYS
Eric WarrenChief Commercial OfficerJun 26, 2026
Sale
$25.90104,124$2.7M38,400
MLYS
Eric WarrenChief Commercial OfficerJun 26, 2026
Option Exercise
$13.24104,124$1.4M142,524
MLYS
Warren Eric—Jun 26, 2026
Proposed Sale
$25.90104,124$2.7M—
ESPR
Warren Eric—Apr 17, 2025
Proposed Sale
$0.9775108$106—
ESPR
Warren Eric—Mar 18, 2025
Proposed Sale
$1.492,433$3.6K—
ESPR
Warren Eric—Feb 19, 2025
Proposed Sale
$1.87239$446—
ESPR
Warren Eric—Jan 17, 2025
Proposed Sale
$2.26123$278—
ESPR
Warren Eric—Dec 17, 2024
Proposed Sale
$2.432,234$5.4K—
ESPR
Warren Eric—Nov 19, 2024
Proposed Sale
$2.17197$427—
ESPR
Warren Eric—Oct 17, 2024
Proposed Sale
$2.12107$227—
ESPR
Warren Eric—Sep 17, 2024
Proposed Sale
$1.782,608$4.7K—